Category-defining partnership between industry leaders brings unprecedented readiness, sophistication, and design ...
The null finding held up even when researchers sliced the data by geography, income, insurance type, and social vulnerability ...
A critical architectural decision lies at the heart of this challenge: whether identity should be managed through centralised ...
Ligand-based drug design combines AI and QSAR modeling to prioritize drug candidates, minimizing preclinical failures and ...
North American lithium producer Elevra Lithium Limited ('Elevra or Company”) (ASX:ELV; NASDAQ:ELVR) announced today the outcomes of an Updated Scoping Study for expansion of the existing North ...
After the rofecoxib (Vioxx) withdrawal in 2004 made painfully clear how much harm a passive reporting system can miss, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results